STELAZINE Drug Patent Profile
✉ Email this page to a colleague
When do Stelazine patents expire, and when can generic versions of Stelazine launch?
Stelazine is a drug marketed by Glaxosmithkline and is included in one NDA.
The generic ingredient in STELAZINE is trifluoperazine hydrochloride. There are ten drug master file entries for this compound. Five suppliers are listed for this compound. Additional details are available on the trifluoperazine hydrochloride profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Stelazine
A generic version of STELAZINE was approved as trifluoperazine hydrochloride by SANDOZ on December 31st, 1969.
Summary for STELAZINE
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 93 |
Patent Applications: | 172 |
Formulation / Manufacturing: | see details |
DailyMed Link: | STELAZINE at DailyMed |
Anatomical Therapeutic Chemical (ATC) Classes for STELAZINE
US Patents and Regulatory Information for STELAZINE
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Glaxosmithkline | STELAZINE | trifluoperazine hydrochloride | CONCENTRATE;ORAL | 011552-006 | Approved Prior to Jan 1, 1982 | DISCN | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Glaxosmithkline | STELAZINE | trifluoperazine hydrochloride | TABLET;ORAL | 011552-002 | Approved Prior to Jan 1, 1982 | DISCN | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Glaxosmithkline | STELAZINE | trifluoperazine hydrochloride | INJECTABLE;INJECTION | 011552-005 | Approved Prior to Jan 1, 1982 | DISCN | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Glaxosmithkline | STELAZINE | trifluoperazine hydrochloride | TABLET;ORAL | 011552-001 | Approved Prior to Jan 1, 1982 | DISCN | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Glaxosmithkline | STELAZINE | trifluoperazine hydrochloride | TABLET;ORAL | 011552-004 | Approved Prior to Jan 1, 1982 | DISCN | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Glaxosmithkline | STELAZINE | trifluoperazine hydrochloride | TABLET;ORAL | 011552-003 | Approved Prior to Jan 1, 1982 | DISCN | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |